Examining the Concordance of Patient Age Distribution between Genitourinary (GU) Clinical Trials and Real-World Disease Populations: Kidney, Prostate and Bladder Cancer Analysis

Ann Surg Oncol. 2024 Sep;31(9):5504-5506. doi: 10.1245/s10434-024-15559-4. Epub 2024 Jun 17.

Authors

Emma Helstrom¹, Ankita Lakshmanan¹, Antoniy Fulmes², Mohit Sindhani³, Ilaha Isali³, Pedro Barata³, Laura Bukavina⁴

Affiliations

¹ Fox Chase Cancer Center, Philadelphia, PA, USA.
² Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
³ Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve School of Medicine, Cleveland, OH, 44106, USA.
⁴ Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, OH, USA. laura.bukavina@fccc.edu.

PMID: 38884899
DOI: 10.1245/s10434-024-15559-4

No abstract available

Publication types

Editorial
Letter

MeSH terms

Age Distribution
Aged
Clinical Trials as Topic
Female
Humans
Kidney Neoplasms* / pathology
Male
Prognosis
Prostatic Neoplasms* / pathology
Urinary Bladder Neoplasms* / pathology
Urogenital Neoplasms / therapy